{"id":"https://openalex.org/W2557532012","doi":"https://doi.org/10.1182/blood.v124.21.2837.2837","title":"The Diversity of Anti-Factor VIII B-Cell Epitopes in Hemophilia a Patients with Inhibitors","display_name":"The Diversity of Anti-Factor VIII B-Cell Epitopes in Hemophilia a Patients with Inhibitors","publication_year":2014,"publication_date":"2014-12-06","ids":{"openalex":"https://openalex.org/W2557532012","doi":"https://doi.org/10.1182/blood.v124.21.2837.2837","mag":"2557532012"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v124.21.2837.2837","doi":"https://doi.org/10.1182/blood.v124.21.2837.2837","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v124.21.2837.2837","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Margaret A. Robinson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Margaret A. Robinson","raw_affiliation_strings":["Emory University School of Medicine, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory University School of Medicine, Atlanta, GA","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109088840","display_name":"Courtney L. Cox","orcid":"https://orcid.org/0000-0001-8930-2053","observed_orcids":["https://orcid.org/0000-0001-8930-2053"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I4210146983","display_name":"Children's Healthcare of Atlanta","ror":"https://ror.org/050fhx250","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146983"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Courtney Cox","raw_affiliation_strings":["Emory University/Children's Healthcare of Atlanta, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory University/Children's Healthcare of Atlanta, Atlanta, GA","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4210146983"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038275899","display_name":"Wallace Hunter Baldwin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I4210146983","display_name":"Children's Healthcare of Atlanta","ror":"https://ror.org/050fhx250","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146983"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Wallace Hunter Baldwin","raw_affiliation_strings":["Emory University/Children's Healthcare of Atlanta, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory University/Children's Healthcare of Atlanta, Atlanta, GA","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4210146983"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067940011","display_name":"Philip M. Zakas","orcid":"https://orcid.org/0000-0002-4919-5182","observed_orcids":["https://orcid.org/0000-0002-4919-5182"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Philip Zakas","raw_affiliation_strings":["Emory University, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory University, Atlanta, GA","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000105274","display_name":"Shannon L. Meeks","orcid":"https://orcid.org/0000-0002-3683-8644","observed_orcids":["https://orcid.org/0000-0002-3683-8644"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I4210146983","display_name":"Children's Healthcare of Atlanta","ror":"https://ror.org/050fhx250","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146983"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shannon L Meeks","raw_affiliation_strings":["Emory University/Children's Healthcare of Atlanta, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory University/Children's Healthcare of Atlanta, Atlanta, GA","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4210146983"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5038275899","https://openalex.org/A5067940011","https://openalex.org/A5109088840"],"corresponding_institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4210146983"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.2047,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.62780779,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"124","issue":"21","first_page":"2837","last_page":"2837"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hemophilia-a","display_name":"hemophilia A","score":0.9490000009536743},{"id":"https://openalex.org/keywords/factor-viii-inhibitors","display_name":"factor VIII inhibitors","score":0.9620000123977661},{"id":"https://openalex.org/keywords/anti-factor-viii-antibodies","display_name":"anti-factor VIII antibodies","score":0.8679999709129333},{"id":"https://openalex.org/keywords/b-cell-epitopes","display_name":"B-cell epitopes","score":0.949999988079071},{"id":"https://openalex.org/keywords/epitope-mapping","display_name":"epitope mapping","score":0.8370000123977661},{"id":"https://openalex.org/keywords/competitive-elisa","display_name":"competitive ELISA","score":0.878000020980835},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.8809999823570251},{"id":"https://openalex.org/keywords/a2-domain","display_name":"A2 domain","score":0.828000009059906},{"id":"https://openalex.org/keywords/c2-domain","display_name":"C2 domain","score":1.0},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.6520000100135803},{"id":"https://openalex.org/keywords/hiv-negative-patients","display_name":"HIV-negative patients","score":0.531000018119812},{"id":"https://openalex.org/keywords/factor-viii-replacement-therapy","display_name":"factor VIII replacement therapy","score":0.3889999985694885}],"concepts":[{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.9643142223358154},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6969200372695923},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6598997116088867},{"id":"https://openalex.org/C956191","wikidata":"https://www.wikidata.org/wiki/Q930144","display_name":"Polyclonal antibodies","level":3,"score":0.6503642797470093},{"id":"https://openalex.org/C204628709","wikidata":"https://www.wikidata.org/wiki/Q864854","display_name":"Biotinylation","level":2,"score":0.6413097977638245},{"id":"https://openalex.org/C32611913","wikidata":"https://www.wikidata.org/wiki/Q2166189","display_name":"Titer","level":3,"score":0.551051676273346},{"id":"https://openalex.org/C2781241564","wikidata":"https://www.wikidata.org/wiki/Q1347450","display_name":"Epitope mapping","level":4,"score":0.5462812781333923},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.5135540962219238},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4449818730354309},{"id":"https://openalex.org/C141440757","wikidata":"https://www.wikidata.org/wiki/Q7226238","display_name":"Polyclonal B cell response","level":5,"score":0.44076991081237793},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.35789334774017334},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.34291765093803406},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.33483389019966125},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3079878091812134},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.2601606845855713},{"id":"https://openalex.org/C157695867","wikidata":"https://www.wikidata.org/wiki/Q1100474","display_name":"B-cell receptor","level":4,"score":0.10259515047073364}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v124.21.2837.2837","doi":"https://doi.org/10.1182/blood.v124.21.2837.2837","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v124.21.2837.2837","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.5699999928474426}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2139059040","https://openalex.org/W1490717836","https://openalex.org/W1966323553","https://openalex.org/W2171051267","https://openalex.org/W2099036832","https://openalex.org/W2013424907","https://openalex.org/W1986671182","https://openalex.org/W1547072551","https://openalex.org/W1981161500","https://openalex.org/W2146940419"],"abstract_inverted_index":{"Abstract":[0],"The":[1,168,317,363],"most":[2,52],"significant":[3],"complication":[4],"in":[5,22,73,81,97,103,106,161,322,336,366,446,504,527,541,564,587,608,628],"the":[6,16,27,45,51,55,74,82,86,115,128,180,198,205,208,216,223,226,257,267,323,331,337,352,397,416,432,505,517,545,552,558,574,579,582,593,598,604,619],"management":[7],"of":[8,18,26,130,152,163,171,182,190,200,210,225,236,266,319,325,333,339,450,456,466,472,484,489,516,534,560,581,600,603,621,640],"patients":[9,247,276,507,519,536,588],"with":[10,31,42,65,135,140,148,248,306,373,384,439,454,461,470,477,487,494,508,520,567,589],"hemophilia":[11,32,245,342,512,590],"A":[12,33,246,269,343,402,591],"continues":[13],"to":[14,24,40,44,100,133,145,185,214,220,229,330,414,551,576,585,617,624,642],"be":[15],"development":[17],"anti-factor":[19],"VIII":[20],"antibodies":[21,43,138,372,383],"response":[23,39,99,228,584,629],"infusions":[25],"fVIII":[28,41,101,206,230,586],"protein.":[29],"Patients":[30],"typically":[34],"develop":[35],"a":[36,104,123,187,193,232,296,301,462],"polyclonal":[37],"B-cell":[38],"A2":[46,56,75,116],"and":[47,57,77,240,260,380,399,428,497],"C2":[48,58,83,87,156],"domains":[49],"being":[50],"prevalent.":[53],"Within":[54,85],"domains,":[59],"we":[60,121],"have":[61],"identified":[62,203],"non-overlapping":[63,71,79,154,201,374,385],"epitopes":[64,72,80,142,191,202,375,524,607],"unique":[66],"characteristics.":[67],"There":[68],"are":[69],"5":[70],"domain":[76,157],"3":[78,153,381,419],"domain.":[84,117],"domain,":[88],"antibody":[89,177,394],"epitope":[90,539,561,595],"was":[91,159,213,272,293,328,348,354,406,502],"more":[92,356],"important":[93],"than":[94,357],"inhibitory":[95,393,420,569],"titer":[96,421],"predicting":[98],"treatment":[102],"murine":[105],"vivo":[107],"bleeding":[108],"model.":[109],"Similar":[110],"findings":[111],"were":[112,251,254,284,369,525],"seen":[113,160],"within":[114],"In":[118,514],"previous":[119,217,553],"studies":[120],"developed":[122],"competition":[124,218,298,438,460,476,493,501],"ELISA":[125,219,299],"that":[126],"assessed":[127,178],"ability":[129],"patient":[131,166,307,326,565,612],"plasma":[132,172,195,308,327,344,434],"compete":[134],"biotinylated":[136,303],"monoclonal":[137,176],"(MAbs)":[139],"known":[141],"for":[143,174,312],"binding":[144,321,335,353],"fVIII.":[146],"Competition":[147,347],"at":[149,440,528,592,609],"least":[150,441,529,610],"1":[151,442,479,496,530,633],"anti-fVIII":[155,364],"MAbs":[158,365],"19":[162],"26":[164],"(73%)":[165],"plasmas.":[167],"high":[169,568],"volume":[170,235],"needed":[173],"each":[175,409,602],"restricts":[179],"use":[181],"this":[183,211,367,622],"assay":[184,405,623],"map":[186],"limited":[188,241],"number":[189,199],"from":[192,244,256,274,280,286,395],"single":[194,270,302,463],"sample.":[196],"Given":[197,597],"on":[204,408],"protein,":[207],"goal":[209],"study":[212,368],"modify":[215],"better":[221,577],"define":[222,626],"diversity":[224,559,572],"immune":[227,583],"using":[231,295],"clinically":[233],"feasible":[234],"plasma.":[237],"Plasma":[238],"samples":[239,279,435,522],"clinical":[242],"data":[243],"inhibitors":[249],"who":[250],"HIV":[252],"negative":[253],"obtained":[255],"Biologic":[258],"Specimen":[259],"Data":[261],"Repository":[262],"Information":[263],"Center":[264],"(BioLINCC)":[265],"NHLBI.":[268],"sample":[271,410,531],"available":[273,285],"27":[275],"while":[277],"2":[278,358,481,521],"different":[281],"time":[282],"periods":[283],"an":[287],"additional":[288],"23":[289,518],"patients.":[290,631],"Epitope":[291],"mapping":[292],"performed":[294,407],"modified":[297,403],"utilizing":[300],"MAb":[304,320,334,443,606],"concentration":[305],"(~50":[309],"\u00b5l":[310],"total":[311],"all":[313],"experiments)":[314],"diluted":[315],"1:40.":[316],"rate":[318,332,549],"presence":[324,338],"compared":[329,550],"control":[340],"severe":[341],"without":[345],"inhibitors.":[346],"considered":[349],"present":[350,563],"when":[351],"reduced":[355],"standard":[359],"deviations":[360],"below":[361],"control.":[362],"4":[370],"anti-A2":[371],"(A2-A,":[376],"A2-B,":[377],"A2-D,":[378],"A2-E)":[379],"anti-C2":[382],"epitopes(C2-A,":[386],"C2-B,":[387],"C2-C)":[388],"as":[389,391,444],"well":[390],"one":[392,611],"both":[396,542],"A3":[398],"C1":[400],"domains.":[401],"Bethesda":[404],"which":[411],"allowed":[412],"us":[413],"group":[415],"plasmas":[417,452,468,486,566],"into":[418],"ranges:":[422],"<":[423],"6":[424,506],"BU/ml,":[425,427],"6-16":[426,473],">16":[429,490],"BU/ml.":[430],"Of":[431],"73":[433],"20":[436,467],"showed":[437,459,475,492],"shown":[445],"Table":[447,632,634],"1.":[448,635],"Six":[449],"36":[451],"(17%)":[453],"titers":[455,471,488],"<6":[457],"BU/ml":[458,474,491],"MAb.":[464],"Three":[465],"(15%)":[469],"either":[478],"or":[480,510],"MAbs.":[482,499],"Eleven":[483],"17":[485],"between":[495,630],"9":[498,605],"No":[500,637],"detected":[503,526],"moderate":[509],"mild":[511],"A.":[513],"12":[515],"available,":[523],"but":[532],"none":[533],"these":[535],"had":[537],"identical":[538],"spectra":[540,562],"samples.":[543],"Despite":[544],"lower":[546],"overall":[547],"detection":[548],"assay,":[554],"our":[555],"results":[556],"highlight":[557],"titers.":[570],"This":[571],"underscores":[573],"need":[575],"understand":[578],"makeup":[580],"individual":[594],"level.":[596],"success":[599],"detecting":[601],"plasma,":[613],"work":[614],"is":[615],"ongoing":[616],"improve":[618],"sensitivity":[620],"further":[625],"differences":[627],"Disclosures":[636],"relevant":[638],"conflicts":[639],"interest":[641],"declare.":[643]},"counts_by_year":[{"year":2015,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2025-10-10T00:00:00"}